Prime plc has successfully achieved financial close on two projects on a shared plot of land close to Royal Surrey County Hospital. A multi-storey car park (MSCP) to serve hospital staff and the new GenesisCare Cancer Centre will soon begin construction after receiving planning permission from Guildford Borough Council earlier this year.
The new cancer centre will offer the latest innovations in cancer treatments. It will provide services to private patients and will also be accessed by Royal Surrey NHS Foundation Trust (RSCH) to treat NHS patients, ensuring excellent cancer care for people across the region. As a result of the development, RSCH will become the third NHS trust nationally to be able to offer access to an MRI Linear Accelerator (MR Linac), providing cutting-edge diagnosis and treatment to NHS patients.
The milestone of financial close marks the culmination of two years of complex work to define the needs of the clients and end-users to create two facilities that support outstanding outcomes for the local health system. It is an especially significant moment for Prime, with the cancer centre being the first facility of this kind to be developed by the business.
The new six-storey MSCP will provide 600 parking spaces for staff. It will incorporate 30 electric car charging points, infrastructure for 30 more in the future and a security office with 100% coverage CCTV. This will free up additional parking capacity for visitors and patients attending the main hospital who have struggled with availability of spaces for a number of years.
Both developments are being built by VINCI Construction. Work is expected to start on site in May 2022 with construction on the car park anticipated to complete in spring of 2023 and the cancer centre in the autumn.
Bob Smaylen, Development Director for Prime said: “It’s always exciting to achieve the financial close of a project, reaching the moment when all partners commit and a concept becomes a reality. It’s an important milestone for Prime and for GenesisCare who, as leaders in cancer care, will be able to provide access to ground-breaking treatment to their patients in the region.”